Fcγ receptor IIIb polymorphism and use of glucocorticoids at baseline are associated with infusion reactions to infliximab in patients with rheumatoid arthritis

OBJECTIVE: Infusion reaction is a major adverse event in patients with rheumatoid arthritis (RA) treated with infliximab. The possible factors including Fcγ receptor (FcγR) polymorphism associated with the development of infusion reactions in patients with RA receiving infliximab were prospectively...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Okuyama, Ayumi, Nagasawa, Hayato, Suzuki, Katsuya, Kameda, Hideto, Kondo, Harumi, Amano, Kouichi, Takeuchi, Tsutomu
Формат: Artigo
Язык:Inglês
Опубликовано: BMJ Group 2010
Предметы:
Clinical and Epidemiological Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3015102/
https://ncbi.nlm.nih.gov/pubmed/20980704
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2010.136283
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы